Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells
- PMID: 11522025
Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells
Abstract
Endothelial cell migration is stimulated by members of the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) families, and is dependent on extracellular proteolytic activity provided by enzymes of the plasminogen activator (PA) system. Here we report that in bovine microvascular endothelial cells (BME cells), bFGF principally increased urokinase-type PA (u-PA) while tissue-type PA (t-PA) was increased mainly by VEGF. In bovine aortic endothelial cells (BAE cells), bFGF increased u-PA, whereas VEGF had no effect. Co-added bFGF and VEGF increased t-PA mRNA levels and enzyme activity in both cell types in a synergistic manner. Tissue-type plasminogen activator (t-PA) immunoreactivity colocalized with von Willebrand factor, a marker for Weibel-Palade bodies. Co-added bFGF and VEGF increased the number of t-PA-positive cells as well as the number of t-PA-positive granules per cell. Localization of t-PA in regulated storage granules endows endothelial cells with the potential to rapidly increase proteolytic activity in the pericellular environment.
Similar articles
-
Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.J Cell Physiol. 1998 Dec;177(3):439-52. doi: 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2. J Cell Physiol. 1998. PMID: 9808152
-
In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.Exp Cell Res. 1994 Feb;210(2):298-305. doi: 10.1006/excr.1994.1042. Exp Cell Res. 1994. PMID: 7507853
-
Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.Lab Invest. 1996 Aug;75(2):249-62. Lab Invest. 1996. PMID: 8765325
-
Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.EXS. 1997;79:391-411. doi: 10.1007/978-3-0348-9006-9_16. EXS. 1997. PMID: 9002228 Review.
-
Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor.J Soc Gynecol Investig. 1999 Jan-Feb;6(1):3-10. J Soc Gynecol Investig. 1999. PMID: 10065419 Review.
Cited by
-
Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span.Am J Pathol. 2004 Jul;165(1):11-24. doi: 10.1016/S0002-9440(10)63271-3. Am J Pathol. 2004. PMID: 15215158 Free PMC article.
-
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380. Int J Mol Sci. 2021. PMID: 33922229 Free PMC article. Review.
-
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.J Neuroinflammation. 2012 Jun 29;9:149. doi: 10.1186/1742-2094-9-149. J Neuroinflammation. 2012. PMID: 22747686 Free PMC article.
-
Adenosine receptor agonists for promotion of dermal wound healing.Biochem Pharmacol. 2009 Apr 1;77(7):1117-24. doi: 10.1016/j.bcp.2008.11.002. Epub 2008 Nov 12. Biochem Pharmacol. 2009. PMID: 19041853 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous